Viewing nowLipitor 20mg (Atorvastatin Calcium Trihydrate)
Atorvastatin Calcium Trihydrate 21.7mg
Tablet · Prescription medication
Jongkundang Co., Ltd.

MFDS item code 200709390 · Notified 2007.08.09 · Insurance code 643300660
Improvement of hyperlipidemia (including pediatric familial hyperlipidemia); prevention of cardiovascular diseases
This medication helps reduce the risk of cardiovascular disease. In particular, it decreases the risk of myocardial infarction and stroke in adults with multiple risk factors for coronary heart disease and in patients with type 2 diabetes. Furthermore, it lowers the risk of non-fatal myocardial infarction, stroke, vascular procedures, hospitalizations for congestive heart failure, and angina in adults with heart disease. Additionally, it decreases total cholesterol and LDL cholesterol levels in patients with hyperlipidemia while increasing HDL cholesterol. This medication is also effective in patients with familial hypercholesterolemia and in pediatric patients when they meet certain risk criteria. Therefore, it is used for the prevention of cardiovascular disease and the treatment of hyperlipidemia.
Patients should follow a standard cholesterol-lowering diet before and during treatment with atorvastatin. The medicine may be taken at any time of day, with or without food. 1. Hyperlipidemia The recommended initial dose is 10 mg of atorvastatin once daily. For patients requiring a greater reduction in LDL cholesterol, treatment may be initiated with 20 mg or 40 mg once daily (only for patients requiring a reduction in LDL cholesterol of 45 % or more). This medicine is administered once daily in a dose range of 10 ~ 80 mg. The initial and maintenance doses should be individualized according to the patient's characteristics, taking treatment goals and response into consideration. Analyze lipid levels within 2 ~ 4 weeks after starting treatment and/or titrating the dose, and adjust the dose accordingly. Since the goal of treatment is to lower LDL cholesterol, LDL cholesterol measurement is recommended when initiating treatment and assessing response. However, if LDL cholesterol levels are unavailable, total cholesterol levels should be used to monitor treatment response. Patients with homozygous familial hypercholesterolemia The dose of this medicine is 10 ~ 80 mg once daily. It is administered in combination with other lipid-lowering therapies (e.g., LDL apheresis) or when such lipid-lowering therapies are not available. ○ Patients with renal impairment: Renal disease does not affect plasma concentrations of atorvastatin or its LDL cholesterol-lowering effect; therefore, dose adjustment is not necessary. ○ Elderly patients: Efficacy and safety in patients aged 70 years or older are generally similar to those in the adult patient population.
10 ~ 17 years: The recommended initial dose is 10 mg of this medicine per day, and the recommended maximum dose is 20 mg per day (there are no clinical data on doses higher than 20 mg of this medicine in pediatric patients). Adjust the dose as appropriate according to the recommended treatment goals for each patient. Adjust the dose at intervals of 4 weeks or more.
This medication can cause muscle-related problems, so if symptoms of muscle pain or weakness occur, consult a doctor immediately. If there is a high risk of muscle damage, it may be necessary to discontinue the medication. It should not be used by individuals with liver dysfunction or liver disease, and liver function tests should be conducted regularly. Pregnant or potentially pregnant women and nursing mothers should not take this medication. It is not recommended for children under 10. There may be drug interactions if taken with specific medications, so you must inform your doctor if you are taking any other medications. Patients with a history of alcohol abuse or liver disease should use caution. Elderly patients are at higher risk for muscle problems, so care is needed in administration. In case of overdose, there is no specific antidote, and treatment should be based on symptoms while monitoring liver function and muscle condition. Store in a place out of reach of children and keep in the original container.
Not everyone experiences these, and they can vary from person to person.
Store this medication in a tightly sealed container to protect it from air and moisture, and it is best to keep it at room temperature between 1 and 30 degrees Celsius. Proper storage will help maintain the effectiveness of the medication and ensure its safe use.
White oval film-coated tablet
30 tablets (10 tablets/PTP packaging x 3), 30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowAtorvastatin Calcium Trihydrate 21.7mg
Tablet · Prescription medication
Jongkundang Co., Ltd.

Atorvastatin Calcium Trihydrate 21.7mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 43.4mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 10.85mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 10.85mg
Tablet · Prescription medication
Kyungdong Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 21.69mg
Tablet · Prescription medication
Shinil Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 21.69mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 10.845mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.